Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Minoxidil with propranolol and diuretics lowers blood pressure but causes fluid retention and hair growth.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Different soft tissue fillers can cause various skin reactions; biodegradable fillers are safer and non-biodegradable ones like silicone can lead to long-term problems.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

Multiphoton microscopy is a promising tool for detailed skin imaging and could improve patient care if its challenges are addressed.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Plant-based ingredients are effective and safe for modern skincare products.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

The document suggests that the traditional understanding of hair growth cycles and alopecia may be inaccurate and that blood supply plays a significant role in hair growth and loss.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Both vertical and transverse sections are useful for diagnosing alopecia, but using both methods together is best.

Finasteride effectively treats hair loss in transgender men with few side effects.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.